APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor Concentrates

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Coagulation Factor Concentrates Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchCoagulation Factor Concentrates Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor Concentrates Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Coagulation Factor Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor Concentrates Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor Concentrates Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Coagulation Factor Concentrates market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Coagulation Factor Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coagulation Factor Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Coagulation Factor Concentrates market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Coagulation Factor Concentrates market include Bio Product Laboratory (UK), Biotest (Germany), CSL (Australia), Green Cross Corporation (South Korea), Grifols (Spain), Japan Blood Products Organization, China Biologic Products (China), Kedrion (Italy), LFB (France) and Octapharma (Switzerland), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coagulation Factor Concentrates market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coagulation Factor Concentrates and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coagulation Factor Concentrates sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coagulation Factor Concentrates market size, projected growth trends, production technologies, key applications, and end-use industries.

Coagulation Factor Concentrates Segment by Company

Bio Product Laboratory (UK)

Biotest (Germany)

CSL (Australia)

Green Cross Corporation (South Korea)

Grifols (Spain)

Japan Blood Products Organization, China Biologic Products (China)

Kedrion (Italy)

LFB (France)

Octapharma (Switzerland)

Sanquin (Netherlands)

Shire (Ireland)

Shanghai RAAS Blood Products (China)

Coagulation Factor Concentrates Segment by Type

Factor XIII

Factor VIII

Factor IX

Fibrinogen Concentrates

Prothrombin Complex Concentrates

Von Willebrand Factor

Coagulation Factor Concentrates Segment by Application

Pulmonology

Rheumatology

Immunology

Neurology

Hematology

Hemato-Oncology

Critical Care

Others

Coagulation Factor Concentrates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Coagulation Factor Concentrates status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Coagulation Factor Concentrates market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Coagulation Factor Concentrates significant trends, drivers, influence factors in global and regions.

6. To analyze Coagulation Factor Concentrates competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor Concentrates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coagulation Factor Concentrates market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coagulation Factor Concentrates industry.

Chapter 3: Detailed analysis of Coagulation Factor Concentrates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Coagulation Factor Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Coagulation Factor Concentrates in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Coagulation Factor Concentrates Industry Trends Table 2. Coagulation Factor Concentrates Industry Drivers Table 3. Coagulation Factor Concentrates Industry Opportunities and Challenges Table 4. Coagulation Factor Concentrates Industry Restraints Table 5. Global Coagulation Factor Concentrates Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Coagulation Factor Concentrates Revenue Share by Company (2021-2026) Table 7. Global Coagulation Factor Concentrates Sales Volume by Company (k units) & (2021-2026) Table 8. Global Coagulation Factor Concentrates Sales Volume Share by Company (2021-2026) Table 9. Global Coagulation Factor Concentrates Average Price (US$/unit) of Company (2021-2026) Table 10. Global Coagulation Factor Concentrates Company Ranking, (2024-2026) & (USD Million) Table 11. Global Coagulation Factor Concentrates Key Company Manufacturing Base & Headquarters Table 12. Global Coagulation Factor Concentrates Company, Product Type & Application Table 13. Global Coagulation Factor Concentrates Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Coagulation Factor Concentrates by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Factor XIII Table 18. Significant Companies of Factor VIII Table 19. Significant Companies of Factor IX Table 20. Significant Companies of Fibrinogen Concentrates Table 21. Significant Companies of Prothrombin Complex Concentrates Table 22. Significant Companies of Von Willebrand Factor Table 23. Global Coagulation Factor Concentrates Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Coagulation Factor Concentrates Sales Volume by Type (2021-2026) & (k units) Table 25. Global Coagulation Factor Concentrates Sales Volume by Type (2027-2032) & (k units) Table 26. Global Coagulation Factor Concentrates Sales Volume Share by Type (2021-2026) Table 27. Global Coagulation Factor Concentrates Sales Volume Share by Type (2027-2032) Table 28. Global Coagulation Factor Concentrates Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Coagulation Factor Concentrates Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Coagulation Factor Concentrates Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Coagulation Factor Concentrates Sales Value Share by Type (2021-2026) Table 32. Global Coagulation Factor Concentrates Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Pulmonology Table 34. Significant Companies of Rheumatology Table 35. Significant Companies of Immunology Table 36. Significant Companies of Neurology Table 37. Significant Companies of Hematology Table 38. Significant Companies of Hemato-Oncology Table 39. Significant Companies of Critical Care Table 40. Significant Companies of Others Table 41. Global Coagulation Factor Concentrates Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Coagulation Factor Concentrates Sales Volume by Application (2021-2026) & (k units) Table 43. Global Coagulation Factor Concentrates Sales Volume by Application (2027-2032) & (k units) Table 44. Global Coagulation Factor Concentrates Sales Volume Share by Application (2021-2026) Table 45. Global Coagulation Factor Concentrates Sales Volume Share by Application (2027-2032) Table 46. Global Coagulation Factor Concentrates Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Coagulation Factor Concentrates Sales Value by Application (2021-2026) & (US$ Million) Table 48. Global Coagulation Factor Concentrates Sales Value by Application (2027-2032) & (US$ Million) Table 49. Global Coagulation Factor Concentrates Sales Value Share by Application (2021-2026) Table 50. Global Coagulation Factor Concentrates Sales Value Share by Application (2027-2032) Table 51. Global Coagulation Factor Concentrates Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 52. Global Coagulation Factor Concentrates Sales by Region (2021-2026) & (k units) Table 53. Global Coagulation Factor Concentrates Sales Market Share by Region (2021-2026) Table 54. Global Coagulation Factor Concentrates Sales by Region (2027-2032) & (k units) Table 55. Global Coagulation Factor Concentrates Sales Market Share by Region (2027-2032) Table 56. Global Coagulation Factor Concentrates Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Coagulation Factor Concentrates Sales Value by Region (2021-2026) & (US$ Million) Table 58. Global Coagulation Factor Concentrates Sales Value Share by Region (2021-2026) Table 59. Global Coagulation Factor Concentrates Sales Value by Region (2027-2032) & (US$ Million) Table 60. Global Coagulation Factor Concentrates Sales Value Share by Region (2027-2032) Table 61. Global Coagulation Factor Concentrates Market Average Price (US$/unit) by Region (2021-2026) Table 62. Global Coagulation Factor Concentrates Market Average Price (US$/unit) by Region (2027-2032) Table 63. Global Coagulation Factor Concentrates Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 64. Global Coagulation Factor Concentrates Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 66. Global Coagulation Factor Concentrates Sales Market Share by Country (2021-2026) Table 67. Global Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 68. Global Coagulation Factor Concentrates Sales Market Share by Country (2027-2032) Table 69. Global Coagulation Factor Concentrates Sales Value by Country (2021-2026) & (US$ Million) Table 70. Global Coagulation Factor Concentrates Sales Value Market Share by Country (2021-2026) Table 71. Global Coagulation Factor Concentrates Sales Value by Country (2027-2032) & (US$ Million) Table 72. Global Coagulation Factor Concentrates Sales Value Market Share by Country (2027-2032) Table 73. Bio Product Laboratory (UK) Company Information Table 74. Bio Product Laboratory (UK) Business Overview Table 75. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio Table 77. Bio Product Laboratory (UK) Recent Development Table 78. Biotest (Germany) Company Information Table 79. Biotest (Germany) Business Overview Table 80. Biotest (Germany) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Biotest (Germany) Coagulation Factor Concentrates Product Portfolio Table 82. Biotest (Germany) Recent Development Table 83. CSL (Australia) Company Information Table 84. CSL (Australia) Business Overview Table 85. CSL (Australia) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. CSL (Australia) Coagulation Factor Concentrates Product Portfolio Table 87. CSL (Australia) Recent Development Table 88. Green Cross Corporation (South Korea) Company Information Table 89. Green Cross Corporation (South Korea) Business Overview Table 90. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio Table 92. Green Cross Corporation (South Korea) Recent Development Table 93. Grifols (Spain) Company Information Table 94. Grifols (Spain) Business Overview Table 95. Grifols (Spain) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Grifols (Spain) Coagulation Factor Concentrates Product Portfolio Table 97. Grifols (Spain) Recent Development Table 98. Japan Blood Products Organization, China Biologic Products (China) Company Information Table 99. Japan Blood Products Organization, China Biologic Products (China) Business Overview Table 100. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio Table 102. Japan Blood Products Organization, China Biologic Products (China) Recent Development Table 103. Kedrion (Italy) Company Information Table 104. Kedrion (Italy) Business Overview Table 105. Kedrion (Italy) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio Table 107. Kedrion (Italy) Recent Development Table 108. LFB (France) Company Information Table 109. LFB (France) Business Overview Table 110. LFB (France) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. LFB (France) Coagulation Factor Concentrates Product Portfolio Table 112. LFB (France) Recent Development Table 113. Octapharma (Switzerland) Company Information Table 114. Octapharma (Switzerland) Business Overview Table 115. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio Table 117. Octapharma (Switzerland) Recent Development Table 118. Sanquin (Netherlands) Company Information Table 119. Sanquin (Netherlands) Business Overview Table 120. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio Table 122. Sanquin (Netherlands) Recent Development Table 123. Shire (Ireland) Company Information Table 124. Shire (Ireland) Business Overview Table 125. Shire (Ireland) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Shire (Ireland) Coagulation Factor Concentrates Product Portfolio Table 127. Shire (Ireland) Recent Development Table 128. Shanghai RAAS Blood Products (China) Company Information Table 129. Shanghai RAAS Blood Products (China) Business Overview Table 130. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio Table 132. Shanghai RAAS Blood Products (China) Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Coagulation Factor Concentrates Distributors List Table 136. Coagulation Factor Concentrates Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Coagulation Factor Concentrates Product Image Figure 2. Global Coagulation Factor Concentrates Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor Concentrates Sales Value (2021-2032) & (US$ Million) Figure 4. Global Coagulation Factor Concentrates Sales (2021-2032) & (k units) Figure 5. Global Coagulation Factor Concentrates Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Coagulation Factor Concentrates Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Factor XIII Image Figure 10. Factor VIII Image Figure 11. Factor IX Image Figure 12. Fibrinogen Concentrates Image Figure 13. Prothrombin Complex Concentrates Image Figure 14. Von Willebrand Factor Image Figure 15. Global Coagulation Factor Concentrates Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Coagulation Factor Concentrates Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Coagulation Factor Concentrates Sales Volume Share by Type (2021-2032) Figure 18. Global Coagulation Factor Concentrates Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Coagulation Factor Concentrates Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Coagulation Factor Concentrates Sales Value Share by Type (2021-2032) Figure 21. Pulmonology Image Figure 22. Rheumatology Image Figure 23. Immunology Image Figure 24. Neurology Image Figure 25. Hematology Image Figure 26. Hemato-Oncology Image Figure 27. Critical Care Image Figure 28. Others Image Figure 29. Global Coagulation Factor Concentrates Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Coagulation Factor Concentrates Sales Volume Share 2021 VS 2025 VS 2032 Figure 31. Global Coagulation Factor Concentrates Sales Volume Share by Application (2021-2032) Figure 32. Global Coagulation Factor Concentrates Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Coagulation Factor Concentrates Sales Value Share 2021 VS 2025 VS 2032 Figure 34. Global Coagulation Factor Concentrates Sales Value Share by Application (2021-2032) Figure 35. Global Coagulation Factor Concentrates Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 36. Global Coagulation Factor Concentrates Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 37. Global Coagulation Factor Concentrates Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 38. Global Coagulation Factor Concentrates Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 39. North America Coagulation Factor Concentrates Sales Value (2021-2032) & (US$ Million) Figure 40. North America Coagulation Factor Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Europe Coagulation Factor Concentrates Sales Value (2021-2032) & (US$ Million) Figure 42. Europe Coagulation Factor Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Asia-Pacific Coagulation Factor Concentrates Sales Value (2021-2032) & (US$ Million) Figure 44. Asia-Pacific Coagulation Factor Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 45. South America Coagulation Factor Concentrates Sales Value (2021-2032) & (US$ Million) Figure 46. South America Coagulation Factor Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 47. Middle East & Africa Coagulation Factor Concentrates Sales Value (2021-2032) & (US$ Million) Figure 48. Middle East & Africa Coagulation Factor Concentrates Sales Value Share by Country (%), 2025 VS 2032 Figure 49. USA Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. USA Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. USA Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Canada Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Canada Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Canada Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Mexico Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Mexico Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Mexico Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Germany Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Germany Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Germany Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. France Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. France Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. France Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. U.K. Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. U.K. Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. U.K. Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Italy Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Italy Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Italy Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Spain Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Spain Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Spain Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Russia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Russia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Russia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Netherlands Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Netherlands Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Netherlands Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Nordic Countries Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Nordic Countries Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Nordic Countries Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. China Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. China Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. China Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Japan Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Japan Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Japan Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. South Korea Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. South Korea Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. South Korea Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. India Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. India Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. India Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Australia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Australia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Australia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Southeast Asia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Southeast Asia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Southeast Asia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Brazil Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Brazil Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Brazil Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Argentina Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Argentina Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Argentina Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Chile Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Chile Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Chile Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Colombia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Colombia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Colombia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Peru Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Peru Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Peru Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Saudi Arabia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Saudi Arabia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Israel Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Israel Arabia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Israel Arabia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. UAE Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. UAE Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. UAE Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Turkey Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Turkey Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Turkey Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Iran Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Iran Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Iran Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Egypt Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 131. Egypt Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032 & (%) Figure 132. Egypt Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032 & (%) Figure 133. Coagulation Factor Concentrates Value Chain Figure 134. Manufacturing Cost Structure Figure 135. Coagulation Factor Concentrates Sales Mode & Process Figure 136. Direct Comparison with Distribution Share Figure 137. Distributors Profiles Figure 138. Years Considered Figure 139. Research Process Figure 140. Key Executives Interviewed

Scope & coverage.

Types
  • Factor XIII
  • Factor VIII
  • Factor IX
  • Fibrinogen Concentrates
  • Prothrombin Complex Concentrates
  • Von Willebrand Factor
Applications
  • Pulmonology
  • Rheumatology
  • Immunology
  • Neurology
  • Hematology
  • Hemato-Oncology
  • Critical Care
  • Others
Companies covered
  • Bio Product Laboratory (UK)
  • Biotest (Germany)
  • CSL (Australia)
  • Green Cross Corporation (South Korea)
  • Grifols (Spain)
  • Japan Blood Products Organization, China Biologic Products (China)
  • Kedrion (Italy)
  • LFB (France)
  • Octapharma (Switzerland)
  • Sanquin (Netherlands)
  • Shire (Ireland)
  • Shanghai RAAS Blood Products (China)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coagulation Factor Concentrates Sales Value (2021-2032)
  4. 1.2.2 Global Coagulation Factor Concentrates Sales Volume (2021-2032)
  5. 1.2.3 Global Coagulation Factor Concentrates Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Coagulation Factor Concentrates Market Dynamics
  1. 2.1 Coagulation Factor Concentrates Industry Trends
  2. 2.2 Coagulation Factor Concentrates Industry Drivers
  3. 2.3 Coagulation Factor Concentrates Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor Concentrates Industry Restraints
3 Coagulation Factor Concentrates Market by Company
  1. 3.1 Global Coagulation Factor Concentrates Company Revenue Ranking in 2025
  2. 3.2 Global Coagulation Factor Concentrates Revenue by Company (2021-2026)
  3. 3.3 Global Coagulation Factor Concentrates Sales Volume by Company (2021-2026)
  4. 3.4 Global Coagulation Factor Concentrates Average Price by Company (2021-2026)
  5. 3.5 Global Coagulation Factor Concentrates Company Ranking (2024-2026)
  6. 3.6 Global Coagulation Factor Concentrates Company Manufacturing Base and Headquarters
  7. 3.7 Global Coagulation Factor Concentrates Company Product Type and Application
  8. 3.8 Global Coagulation Factor Concentrates Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Coagulation Factor Concentrates Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Coagulation Factor Concentrates Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Coagulation Factor Concentrates Market by Type
  1. 4.1 Coagulation Factor Concentrates Type Introduction
  2. 4.1.1 Factor XIII
  3. 4.1.2 Factor VIII
  4. 4.1.3 Factor IX
  5. 4.1.4 Fibrinogen Concentrates
  6. 4.1.5 Prothrombin Complex Concentrates
  7. 4.1.6 Von Willebrand Factor
  8. 4.2 Global Coagulation Factor Concentrates Sales Volume by Type
  9. 4.2.1 Global Coagulation Factor Concentrates Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Coagulation Factor Concentrates Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Coagulation Factor Concentrates Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Coagulation Factor Concentrates Sales Value by Type
  13. 4.3.1 Global Coagulation Factor Concentrates Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Coagulation Factor Concentrates Sales Value by Type (2021-2032)
  15. 4.3.3 Global Coagulation Factor Concentrates Sales Value Share by Type (2021-2032)
5 Coagulation Factor Concentrates Market by Application
  1. 5.1 Coagulation Factor Concentrates Application Introduction
  2. 5.1.1 Pulmonology
  3. 5.1.2 Rheumatology
  4. 5.1.3 Immunology
  5. 5.1.4 Neurology
  6. 5.1.5 Hematology
  7. 5.1.6 Hemato-Oncology
  8. 5.1.7 Critical Care
  9. 5.1.8 Others
  10. 5.2 Global Coagulation Factor Concentrates Sales Volume by Application
  11. 5.2.1 Global Coagulation Factor Concentrates Sales Volume by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Coagulation Factor Concentrates Sales Volume by Application (2021-2032)
  13. 5.2.3 Global Coagulation Factor Concentrates Sales Volume Share by Application (2021-2032)
  14. 5.3 Global Coagulation Factor Concentrates Sales Value by Application
  15. 5.3.1 Global Coagulation Factor Concentrates Sales Value by Application (2021 VS 2025 VS 2032)
  16. 5.3.2 Global Coagulation Factor Concentrates Sales Value by Application (2021-2032)
  17. 5.3.3 Global Coagulation Factor Concentrates Sales Value Share by Application (2021-2032)
6 Coagulation Factor Concentrates Regional Sales and Value Analysis
  1. 6.1 Global Coagulation Factor Concentrates Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coagulation Factor Concentrates Sales by Region (2021-2032)
  3. 6.2.1 Global Coagulation Factor Concentrates Sales by Region: 2021-2026
  4. 6.2.2 Global Coagulation Factor Concentrates Sales by Region (2027-2032)
  5. 6.3 Global Coagulation Factor Concentrates Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Coagulation Factor Concentrates Sales Value by Region (2021-2032)
  7. 6.4.1 Global Coagulation Factor Concentrates Sales Value by Region: 2021-2026
  8. 6.4.2 Global Coagulation Factor Concentrates Sales Value by Region (2027-2032)
  9. 6.5 Global Coagulation Factor Concentrates Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Coagulation Factor Concentrates Sales Value (2021-2032)
  12. 6.6.2 North America Coagulation Factor Concentrates Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Coagulation Factor Concentrates Sales Value (2021-2032)
  15. 6.7.2 Europe Coagulation Factor Concentrates Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Coagulation Factor Concentrates Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Coagulation Factor Concentrates Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Coagulation Factor Concentrates Sales Value (2021-2032)
  21. 6.9.2 South America Coagulation Factor Concentrates Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Coagulation Factor Concentrates Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Coagulation Factor Concentrates Sales Value Share by Country, 2025 VS 2032
7 Coagulation Factor Concentrates Country-level Sales and Value Analysis
  1. 7.1 Global Coagulation Factor Concentrates Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Coagulation Factor Concentrates Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Coagulation Factor Concentrates Sales by Country (2021-2032)
  4. 7.3.1 Global Coagulation Factor Concentrates Sales by Country (2021-2026)
  5. 7.3.2 Global Coagulation Factor Concentrates Sales by Country (2027-2032)
  6. 7.4 Global Coagulation Factor Concentrates Sales Value by Country (2021-2032)
  7. 7.4.1 Global Coagulation Factor Concentrates Sales Value by Country (2021-2026)
  8. 7.4.2 Global Coagulation Factor Concentrates Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Coagulation Factor Concentrates Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Coagulation Factor Concentrates Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Coagulation Factor Concentrates Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bio Product Laboratory (UK)
  2. 8.1.1 Bio Product Laboratory (UK) Company Information
  3. 8.1.2 Bio Product Laboratory (UK) Business Overview
  4. 8.1.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio
  6. 8.1.5 Bio Product Laboratory (UK) Recent Developments
  7. 8.2 Biotest (Germany)
  8. 8.2.1 Biotest (Germany) Company Information
  9. 8.2.2 Biotest (Germany) Business Overview
  10. 8.2.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Biotest (Germany) Coagulation Factor Concentrates Product Portfolio
  12. 8.2.5 Biotest (Germany) Recent Developments
  13. 8.3 CSL (Australia)
  14. 8.3.1 CSL (Australia) Company Information
  15. 8.3.2 CSL (Australia) Business Overview
  16. 8.3.3 CSL (Australia) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CSL (Australia) Coagulation Factor Concentrates Product Portfolio
  18. 8.3.5 CSL (Australia) Recent Developments
  19. 8.4 Green Cross Corporation (South Korea)
  20. 8.4.1 Green Cross Corporation (South Korea) Company Information
  21. 8.4.2 Green Cross Corporation (South Korea) Business Overview
  22. 8.4.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio
  24. 8.4.5 Green Cross Corporation (South Korea) Recent Developments
  25. 8.5 Grifols (Spain)
  26. 8.5.1 Grifols (Spain) Company Information
  27. 8.5.2 Grifols (Spain) Business Overview
  28. 8.5.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Grifols (Spain) Coagulation Factor Concentrates Product Portfolio
  30. 8.5.5 Grifols (Spain) Recent Developments
  31. 8.6 Japan Blood Products Organization, China Biologic Products (China)
  32. 8.6.1 Japan Blood Products Organization, China Biologic Products (China) Company Information
  33. 8.6.2 Japan Blood Products Organization, China Biologic Products (China) Business Overview
  34. 8.6.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio
  36. 8.6.5 Japan Blood Products Organization, China Biologic Products (China) Recent Developments
  37. 8.7 Kedrion (Italy)
  38. 8.7.1 Kedrion (Italy) Company Information
  39. 8.7.2 Kedrion (Italy) Business Overview
  40. 8.7.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio
  42. 8.7.5 Kedrion (Italy) Recent Developments
  43. 8.8 LFB (France)
  44. 8.8.1 LFB (France) Company Information
  45. 8.8.2 LFB (France) Business Overview
  46. 8.8.3 LFB (France) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LFB (France) Coagulation Factor Concentrates Product Portfolio
  48. 8.8.5 LFB (France) Recent Developments
  49. 8.9 Octapharma (Switzerland)
  50. 8.9.1 Octapharma (Switzerland) Company Information
  51. 8.9.2 Octapharma (Switzerland) Business Overview
  52. 8.9.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio
  54. 8.9.5 Octapharma (Switzerland) Recent Developments
  55. 8.10 Sanquin (Netherlands)
  56. 8.10.1 Sanquin (Netherlands) Company Information
  57. 8.10.2 Sanquin (Netherlands) Business Overview
  58. 8.10.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio
  60. 8.10.5 Sanquin (Netherlands) Recent Developments
  61. 8.11 Shire (Ireland)
  62. 8.11.1 Shire (Ireland) Company Information
  63. 8.11.2 Shire (Ireland) Business Overview
  64. 8.11.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shire (Ireland) Coagulation Factor Concentrates Product Portfolio
  66. 8.11.5 Shire (Ireland) Recent Developments
  67. 8.12 Shanghai RAAS Blood Products (China)
  68. 8.12.1 Shanghai RAAS Blood Products (China) Company Information
  69. 8.12.2 Shanghai RAAS Blood Products (China) Business Overview
  70. 8.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio
  72. 8.12.5 Shanghai RAAS Blood Products (China) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coagulation Factor Concentrates Value Chain Analysis
  2. 9.1.1 Coagulation Factor Concentrates Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coagulation Factor Concentrates Sales Mode & Process
  6. 9.2 Coagulation Factor Concentrates Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coagulation Factor Concentrates Distributors
  9. 9.2.3 Coagulation Factor Concentrates Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst